SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001628280-22-025322
Filing Date
2022-09-22
Accepted
2022-09-22 07:41:31
Documents
12
Period of Report
2022-06-22
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K/A cccc-20220622.htm   iXBRL 8-K/A 34767
  Complete submission text file 0001628280-22-025322.txt   174570

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cccc-20220622.xsd EX-101.SCH 1946
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cccc-20220622_lab.xml EX-101.LAB 24849
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cccc-20220622_pre.xml EX-101.PRE 13086
6 EXTRACTED XBRL INSTANCE DOCUMENT cccc-20220622_htm.xml XML 11808
Mailing Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Filer) CIK: 0001662579 (see all company filings)

IRS No.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39567 | Film No.: 221257856
SIC: 2836 Biological Products, (No Diagnostic Substances)